Established and emerging biomarkers in systemic sclerosis: from antibody specificities to molecular signatures and cytokine profiling
Year: 2026
Type: article
Abstract: Systemic sclerosis (SSc) is a systemic autoimmune rheumatic disease characterized by immune dysregulation, microvascular injury and fibrosis of the vessels, skin and internal organs. Biomarkers are critical to establish prognosis and to guide early intervention. This narrative review evaluates the diagnostic utility, pathogenic roles and level of clinical evidence for autoantibodies, soluble proteins, cytokines and genetic loci in SSc, and groups non-antibody markers by the process they mainly reflect. Several studies identified associations between SSc phenotypes and anticentromere, anti-topoisomerase I and anti-RNA polymerase III antibodies, which remain the best-established serological biomarkers, whereas anti-Ro52, anti-Th/To, anti-U3 RNP, anti-BICD2 and functional antibodies define additional organ-specific and vascular phenotypes. Interleukin (IL)-6, IL-1, IL-17, type I interferon signatures and chemokines reflect immune activation; adhesion molecules, soluble endoglin, endostatin and fractalkine reflect endothelial dysfunction; and transforming growth factor-β, IL-4, IL-13, IL-11 and collagen turnover markers reflect fibrogenesis. Krebs von den Lungen-6 (KL-6), the most widely tested marker of SSc-associated interstitial lung disease, and surfactant protein D mainly reflect alveolar epithelial injury. Genetic variants in IRF5, STAT4, TNFAIP3, BANK1 and other loci inform susceptibility rather than diagnosis. These groups are interconnected - inflammation injures the endothelium, vascular injury sustains inflammation and fibroblast activation, and mediators such as IL-6 and transforming growth factor-β act across all three. Apart from classification autoantibodies, most candidates still require external validation before organ-focused biomarker panels can support earlier diagnosis and tailored treatment.
Source: Frontiers in Immunology
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: systemic sclerosis, biomarkers, autoantibodies, anti-centromere antibodies, anti-Scl-70 antibodies, anti-RNA polymerase III antibodies, anti-Ro52 antibodies, cytokine profiling, type I interferon signature, endothelial dysfunction, soluble endoglin, endostatin, fractalkine, fibrogenesis, TGF-beta, interleukin-6, interstitial lung disease, KL-6, surfactant protein D, genetic susceptibility loci, IRF5, STAT4, A20, BANK1, disease classification, early diagnosis
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7235214464
